FY 24 Appropriations (LHHS (S. 2624, HR 5894), CJS (S. 2321, HR 5893), Interior (HR 4821, S. 2605), MilCon (HR 4366, S. 2127)) regarding Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; crisis stabilization and community reentry grants.
Duration: May 6, 2019
to
December 31, 2023
General Issues: Health Issues
Spending: about $560,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2019: House of Representatives, U.S. Senate
Related Foreign Entities:
Alkermes plc (Dublin, IRL); contribution to lobbying: $0; ownership 100%
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Kate Hallahan 2006-16, US House: Dem Clerk, Trans Approp SubCmte; 2001-06, US Senate Prof Staff, Sen Trans Approp SubCmte); 2000-01, FAA Dpty Asst Admnstr for Gov & Industry Affairs; 1997-2000, US DoT, Sr Policy Advsr; 1996-97, US DoT: Spec. Asst to the Secy.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2023
TEAM HALLAHAN LLC terminated an engagement in which they represented Alkermes, Inc. on Jan. 19.
Original Filing: 301531143.xml
Lobbying Issues
FY 24 Appropriations (LHHS (S. 2624, HR 5894), CJS (S. 2321, HR 5893), Interior (HR 4821, S. 2605), MilCon (HR 4366, S. 2127)) regarding Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; crisis stabilization and community reentry grants.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2023
In Q3, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on Oct. 18, 2023.
Original Filing: 301505539.xml
Lobbying Issues
FY 24 Appropriations (LHHS (S. 2624, HR 5894), CJS (S. 2321, HR 5893), Interior (HR 4821, S. 2605), MilCon (HR 4366, S. 2127)) regarding Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; crisis stabilization and community reentry grants.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2023
In Q2, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on July 19, 2023.
Original Filing: 301483050.xml
Lobbying Issues
FY 24 Appropriations (LHHS, CJS, Interior, MilCon) regarding Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; crisis stabilization and community reentry grants.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2023
In Q1, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on April 20, 2023.
Original Filing: 301461021.xml
Lobbying Issues
"FY 23 Appropriations HR 8294, S. 4670; LHHS HR 8295; S. 4659; CJS HR 8256, S 4664 (LHHS, Interior, and Milcon VA) and HR 4505, Commerce Justice State Appropriations regarding Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions, Lower Drug Costs Now Act, Prescription Drug Pricing Reduction Act; crisis stabilization and community reentry grants.
FY 23 Transportation, Housing and Urban DevelopmentAppropriations related to housing pilot for homeless individuals with severe mental illness. FY2023 Consolidated Appropriations Act (HR 2617).
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on Jan. 18, 2023.
Original Filing: 301430234.xml
Lobbying Issues
"FY 23 Appropriations HR 8294, S. 4670; LHHS HR 8295; S. 4659; CJS HR 8256, S 4664 (LHHS, Interior, and Milcon VA) and HR 4505, Commerce Justice State Appropriations regarding Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions, Lower Drug Costs Now Act, Prescription Drug Pricing Reduction Act; crisis stabilization and community reentry grants.
FY 23 Transportation, Housing and Urban DevelopmentAppropriations related to housing pilot for homeless individuals with severe mental illness. FY2023 Consolidated Appropriations Act (HR 2617).
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2022
In Q3, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on Oct. 19, 2022.
Original Filing: 301411681.xml
Lobbying Issues
FY 23 Appropriations HR 8294, S. 4670; LHHS HR 8295; S. 4659; CJS HR 8256, S 4664 (LHHS, Interior, and Milcon VA) and HR 4505, Commerce Justice State Appropriations regarding Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions, Lower Drug Costs Now Act, Prescription Drug Pricing Reduction Act; crisis stabilization and community reentry grants.
FY 23 Transportation, Housing and Urban DevelopmentAppropriations related to housing pilot for homeless individuals with severe mental illness
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2022
In Q2, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on July 19, 2022.
Original Filing: 301386595.xml
Lobbying Issues
FY 22/23 Appropriations HR 4502,(LHHS, Interior, and Milcon VA) and HR 4505, Commerce Justice State Appropriations regarding Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions, Lower Drug Costs Now Act, Prescription Drug Pricing Reduction Act; crisis stabilization and community reentry grants.
FY 23 Transportation, Housing and Urban DevelopmentAppropriations related to housing pilot for homeless individuals with severe mental illness
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2022
In Q1, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on April 19, 2022.
Original Filing: 301362218.xml
Lobbying Issues
FY 22/23 Appropriations HR 4502,(LHHS, Interior, and Milcon VA) and HR 4505, Commerce Justice State Appropriations regarding Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions, Lower Drug Costs Now Act, Prescription Drug Pricing Reduction Act; crisis stabilization and community reentry grants.
FY 23 Transportation, Housing and Urban DevelopmentAppropriations related to housing pilot for homeless individuals with severe mental illness
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2021
In Q4, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on Jan. 19, 2022.
Original Filing: 301329019.xml
Lobbying Issues
FY 22 Appropriations HR 4502,(LHHS, Interior, and Milcon VA) and HR 4505, Commerce Justice State Appropriations regarding Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions, Lower Drug Costs Now Act, Prescription Drug Pricing Reduction Act; crisis stabilization and community reentry grants.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
In Q3, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on Oct. 19, 2021.
Original Filing: 301305760.xml
Lobbying Issues
FY 22 Appropriations HR 4502,(LHHS, Interior, and Milcon VA) and HR 4505, Commerce Justice State Appropriations regarding Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions, Lower Drug Costs Now Act, Prescription Drug Pricing Reduction Act; crisis stabilization and community reentry grants.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2021
In Q2, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on July 20, 2021.
Original Filing: 301287070.xml
Lobbying Issues
FY 22 Appropriations (LHHS, CJS, Interior, and Milcon VA) Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions, Lower Drug Costs Now Act, Prescription Drug Pricing Reduction Act; crisis stabilization and community reentry grants.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2021
In Q1, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on April 20, 2021.
Original Filing: 301259852.xml
Lobbying Issues
FY 2021/22 Appropriations (LHHS, CJS, Interior, and Milcon VA) Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions, Lower Drug Costs Now Act of 2019, Prescription Drug Pricing Reduction Act of 2019;
(FY 21/22 Omnibus and COVID Relief and Response Act)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2020
In Q4, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on Jan. 20, 2021.
Original Filing: 301242127.xml
Lobbying Issues
FY 2021 Appropriations (LHHS, CJS, Interior, and Milcon VA) Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions in HR 3, Lower Drug Costs Now Act of 2019 and S 2543, Prescription Drug Pricing Reduction Act of 2019;
HR 133 (FY 21 Omnibus and COVID Relief and Response Act)
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2020
In Q3, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on Oct. 19, 2020.
Original Filing: 301213183.xml
Lobbying Issues
FY 2021 Appropriations (LHHS, CJS, Interior, and Milcon VA) Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions in HR 3, Lower Drug Costs Now Act of 2019 and S 2543, Prescription Drug Pricing Reduction Act of 2019.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2020
In Q2, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on July 17, 2020.
Original Filing: 301192368.xml
Lobbying Issues
FY 2021 Appropriations (LHHS, CJS, Interior, and Milcon VA) Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions in HR 3, Lower Drug Costs Now Act of 2019 and S 2543, Prescription Drug Pricing Reduction Act of 2019.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2020
In Q1, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on April 20, 2020.
Original Filing: 301175251.xml
Lobbying Issues
FY 2021 Appropriations (LHHS, CJS, Interior, and Milcon VA) Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions in HR 3, Lower Drug Costs Now Act of 2019 and S 2543, Prescription Drug Pricing Reduction Act of 2019.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2019
In Q4, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108182.xml
Lobbying Issues
Comprehensive Opioid Recovery Centers, FY 2020 Appropriations (LHHS, CJS, Int, and Milcon VA) Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Appropriations bills (HR 2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 and HR 3055, H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020);
Medicaid Part D provisions in HR 3, Lower Drug Costs Now Act of 2019 and S 2543, Prescription Drug Pricing Reduction Act of 2019
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $30,000. The report was filed on Oct. 18, 2019.
Original Filing: 301071293.xml
Lobbying Issues
Comprehensive Opioid Recovery Centers, FY 2020 Appropriations (LHHS, CJS, Int, and Milcon VA) Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Appropriations bills (HR 2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 and HR 3055, H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020);
Medicaid Part D provisions in HR 3, Lower Drug Costs Now Act of 2019 and S 2543, Prescription Drug Pricing Reduction Act of 2019
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
In Q2, TEAM HALLAHAN LLC lobbied for Alkermes, Inc. , earning $20,000. The report was filed on July 20, 2019.
Original Filing: 301053393.xml
Lobbying Issues
Comprehensive Opioid Recovery Centers, FY 2020 Appropriations (LHHS, CJS, Int, and Milcon VA) Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Appropriations bills (HR 2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 and HR 3055, H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020)
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
TEAM HALLAHAN LLC filed a lobbying registration on May 13, 2019 to represent Alkermes, Inc., effective May 6, 2019.
Original Filing: 301040782.xml
Issue(s) they said they’d lobby about: Comprehensive Opioid Recovery Centers, FY 2020 Appropriations (LHHS, CJS, Int, and Milcon VA). .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...